Search results
ROVA's 1948-49 team, Part 5: Asplund locked in as Tigers stun Zippers, head to state
The Register-Mail via Yahoo News· 1 year agoLate in the 1948-49 regular season, Monmouth topped the Peoria Journal-Star area basketball...
ROVA's 1948-49 team, Part 6: State tourney: ‘Red’ Kerr, the queen and measles
The Register-Mail via Yahoo News· 1 year agoThat ROVA was the smallest school to reach the Sweet Sixteen was story enough, but adding to the...
ROVA's 1948-49 team, Part 4: ‘We’re going to beat Galesburg next week’
The Register-Mail via Yahoo News· 1 year agoSo-called “bulletin board” material is an element usually associated with professional sports, but...
New ROVA school made history in first hoops season in 1948-49
The Register-Mail via Yahoo News· 1 year agoEditor's Note: This is the first of a six-part series on the first ROVA basketball team. The last...
ROVA 1948-49 team, Part 2: ‘The Rio, Oneida, Victoria, Altona aggregation’ starts strong
The Register-Mail via Yahoo News· 1 year agoEditor's Note: This is the second of a six-part series on the ROVA 1948-49 basketball season. It...
ROVA's 1948-49 team, Part 3: ROVA edges Galva, Abingdon to win pair of tourney titles
The Register-Mail via Yahoo News· 1 year agoEditor's Note: This is the third of a six-part series on the ROVA 1948-49 basketball season. Not...
Novartis licenses Legend cell therapy for lung cancer
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: Novartis is deepening its investment in cancer cell therapy, licensing an experimental...
Voices: After this outrage, it’s time to break up with Love Island for good
The Independent via Yahoo News· 2 years agoLove Island has long been clouded by accusations of sexism, gaslighting and racism. But if you...
Division 4 track finals: Zane Forist, Cavanaugh Barker lead Carson City-Crystal to runner-up finish
Lansing State Journal via Yahoo News· 2 years agoZane Forist broke a few more records. And Cavanaugh Barker had a strong all-around performance. Both...
Merck pays $680M for struggling cancer biotech Harpoon
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: Merck & Co. is beefing up its cancer pipeline, announcing Monday it will pay $680...